Author:
Vázquez-Costa Juan Francisco,Payá-Montes María,Martínez-Molina Marina,Jaijo Teresa,Szymanski Jazek,Mazón Miguel,Sopena-Novales Pablo,Pérez-Tur Jordi,Sevilla Teresa,
Abstract
Background and PurposePrimary lateral sclerosis (PLS) is a progressive upper motor neuron (UMN) disorder. It is debated whether PLS is part of the amyotrophic lateral sclerosis (ALS) spectrum, or a syndrome encompassing different neurodegenerative diseases. Recently, new diagnostic criteria for PLS have been proposed. We describe four patients of two pedigrees, meeting definite PLS criteria and harboring two different mutations in presenilin 1 (PSEN1).MethodsPatients underwent neurological and neuropsychological examination, MRI, 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), amyloid-related biomarkers, and next-generation sequencing (NGS) testing.ResultsFour patients, aged 25–45 years old, presented with a progressive UMN syndrome meeting clinical criteria of definite PLS. Cognitive symptoms and signs were mild or absent during the first year of the disease but appeared or progressed later in the disease course. Brain MRI showed microbleeds in two siblings, but iron-related hypointensities in the motor cortex were absent. Brain FDG-PET showed variable areas of hypometabolism, including the motor cortex and frontotemporal lobes. Amyloid deposition was confirmed with either cerebrospinal fluid (CSF) or imaging biomarkers. Two heterozygous likely pathogenic mutations in PSEN1 (p.Pro88Leu and p.Leu166Pro) were found in the NGS testing.ConclusionClinically defined PLS is a syndrome encompassing different neurodegenerative diseases. The NGS testing should be part of the diagnostic workup in patients with PLS, at least in those with red flags, such as early-onset, cognitive impairment, and/or family history of neurodegenerative diseases.
Funder
Conselleria d'Educació, Investigació, Cultura i Esport
Instituto de Salud Carlos III
Subject
Cellular and Molecular Neuroscience,Molecular Biology
Reference21 articles.
1. Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes.;Brugman;Arch. Neurol.,2009
2. Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.;Erro;J. Neurol.,2019
3. Association Between Globular Glial Tauopathies and Frontotemporal Dementia—Expanding the Spectrum of Gliocentric Disorders.;Forrest;JAMA Neurol.,2021
4. Primary lateral sclerosis (PLS) vs. Hereditary Spastic Paraperesis (HSP) in Presenilin-1 (PSEN1) related dominant dementia.;Jazi;Neurology,2019
5. Concurrent Alzheimer disease and primary lateral sclerosis associated with presenilin-1 gene mutation in a 30-year-old man (1176).;Lewis;Neurology,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献